Financial News
Latest News about BGNE
Recent news which mentions BGNE
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
November 24, 2021
From Benzinga
BeiGene's Brukinsa Approved In Europe For Rare Type Of Blood Cancer
November 24, 2021
Tickers
BGNE
From Benzinga
2 Growth Stocks That Could Deliver 1,000% Returns
October 31, 2021
From Motley Fool
2 Penny Stocks That Could Soar Soon
October 14, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
3 Biotech Stocks That Surged in September
October 05, 2021
From Motley Fool
This Potential Indication Could Be a Winner for Novartis
September 29, 2021
From Motley Fool
Notable Beigene Insider Trades $3.11 Million In Company Stock
September 23, 2021
Tickers
BGNE
From Benzinga
48 Biggest Movers From Friday
September 20, 2021
From Benzinga
Why BeiGene's Shares Jumped on Friday
September 17, 2021
From Motley Fool
Beigene Insider Trades $33.79 Million In Company Stock
September 17, 2021
Tickers
BGNE
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 17, 2021
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 17, 2021
From InvestorPlace
15 Stocks Moving in Friday's Pre-Market Session
September 17, 2021
From Benzinga
Zymeworks' Zanidatamab Aces Mid-Stage Esophageal Cancer Trial
September 16, 2021
From Benzinga
From Benzinga
Leap Therapeutics Stock Is Moving Higher On Updated DKN-01 Combo Trial Data In Gastric Cancer
September 16, 2021
From Benzinga
3 Top Chinese Stocks to Watch in September
September 15, 2021
From Motley Fool
BeiGene's Brukinsa Scores FDA Approval For Marginal Zone Lymphoma
September 15, 2021
Tickers
BGNE
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
3 Stocks Insiders Are Buying
September 14, 2021
From Benzinga
Why Are Leap Therapeutics Shares Trading Higher On Monday?
September 13, 2021
From Benzinga
BeiGene's Brukinsa Scores FDA Approval For Rare Blood Cancer Indication
September 02, 2021
Tickers
BGNE
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.